Concept
Policy Priorities
Canada has the strengths to lead in life sciences. Now will it? - The Globe and Mail / Strength meets a structural gap
"Mr. Magnelli sees a rare opportunity in this moment. In July, the federal government’s Pharmaceutical and Life Sciences Sector Task Force has produced recommendations that government, industry and patient groups broadly agree on, he says, and now is the time to move from recommendations to implementation. Priorities include: modernizing health technology assessment and pan-Canadian Pharmaceutical Alliance (pCPA) approaches to reflect the full clinical, patient and societal value of a treatment; improving time to patient access; reforming Canada’s Drug Agency (CDA-AMC); and enhancing federal investment for innovative medicines."
Related Ideas
- Policy ActionCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Closing the gap, together
- Sector ScaleCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Building on Canada’s advantage
- FAST ProgramCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Ontario’s FAST program is proof it can work
- Access EnvironmentCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Building on Canada’s advantage
- Scaling ApproachesCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Ontario’s FAST program is proof it can work
- Global LeadershipCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Closing the gap, together
- National AdvantagesCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Strength meets a structural gap
- Research NetworkCanada has the strengths to lead in life sciences. Now will it? - The Globe and Mail · Building on Canada’s advantage